NEWARK, N.Y., April 14, 2016 -- Ultralife Corporation (NASDAQ:ULBI) will report its first quarter results for the period ended March 27, 2016 before the market opens on Thursday, April 28, 2016.
Ultralife’s management will also host an investor conference call and simultaneous webcast at 10:00 AM ET on April 28, 2016. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultralife call. A live webcast of the conference call will be available to investors in the Events & Presentations Section of the Company’s website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.
About Ultralife Corporation
Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.
Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit http://www.ultralifecorporation.com.
Company Contact: Ultralife Corporation Philip A. Fain (315) 210-6110 [email protected] Investor Relations Contact: LHA Jody Burfening (212) 838-3777 [email protected]


BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
FDA Approves Mitapivat for Anemia in Thalassemia Patients
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 



